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Abstract
Background: Dexmedetomidine can facilitate a smooth extubation process and reduce the requirement of
sevoflurane and emergence agitation when administrated perioperatively. We aimed to observe the extubation
process and the recovery characteristics in pediatric patients undergoing tonsillectomy while anesthetized with
either high-concentration sevoflurane alone or low-concentration sevoflurane combined with pre-medication of
single dose of intravenous dexmedetomidine.
Methods: Seventy-five patients (ASA I or II, aged 3–7 years) undergoing tonsillectomy were randomized into three
equal groups: to receive intravenous saline (Group D0), dexmedetomidine 1 μg/kg (Group D1), or dexmedetomidine
2 μg/kg (Group D2) approximately 10 min before anesthesia. Before the end of surgery, sevoflurane were adjusted to 1.
5 times, 1.0 time and 0.8 times the minimal effective concentration in groups D0, D1 and D2, respectively. The
sevoflurane concentration for each group was maintained for at least 10 min before the tracheal deep-extubation was
performed. The extubation event, recovery characteristics and post-op respiratory complications were recorded.
Results: All tracheal tubes in three groups were removed successfully during deep anesthesia. Nine patients in Group
D0, three patients in Group D1, and two patients in Group D2 required oral airway to maintain a patent airway after
extubation. The frequency of oral airway usage in groups D1 and D2 were significantly lower than that in Group D0. The
percentages of patients with ED and the requirements of fentanyl in groups D1 and D2 were also significantly lower
than those in Group D0. The time from extubation to spontaneous eye opening in Group D2 was longer than that in
groups D0 and D1. The times of post-anesthesia care unit discharge in groups D0 and D2 were longer than that in
Group D1. No other respiratory complications and vomiting were observed.
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Conclusion: A single dose of intravenous dexmedetomidine as pre-medication in combination with low-concentration
sevoflurane at the end of surgery provided safe and smooth deep extubation condition and it also lowered the
emergence agitation in sevoflurane-anaesthetized children undergoing tonsillectomy. Preoperative dexmedetomidine
at 1 μg/kg did not prolong postoperative recovery time.
Trial registration: Chinese Clinical Trial Registry (ChiCTR): ChiCTR-IOR-16008423, date of registration: 06 may 2016.
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Background
It is always a challenging task to perform smooth extu-
bation while avoiding coughing, bucking, breath holding,
oxygen desaturation, and laryngospasm in children
undergoing adenotonsillectomy. Deep tracheal extuba-
tion technique has advantages over awake extubation by
avoiding some of those complications and it has been
safely performed after anesthesia [1]. However, major
concerns of airway complications remain hunting in an-
esthesiologist’s mind, particularly in young children
undergoing airway surgeries, and with co-existing
obstructive airway diseases and when anesthetized with
inhaled volatile agent, such as sevoflurane.
Dexmedetomidine, a highly selective α-2 adrenergic
agonist, is widely employed perioperatively in children
[2, 3] and it can reduce the requirement for anesthetics
[4, 5], as shown by a previous study that dexmedetomi-
dine could produce a dose-dependent decrease of sevo-
flurane in children, from 33 to 60% [6]. Guler et al. have
found that a single-dose injection of dexmedetomidine
facilitated smooth awake extubation by attenuating the
extubation-induced airway-circulatory reflexes in
children [7, 8].
In this study, we hypothesized that dexmedetomidine,
combined with a low-concentration sevoflurane would
create a smooth deep-extubation condition compared to
the high-concentration sevoflurane anesthesia without
dexmedetomidine in children undergoing adenotonsil-
lectomy. The emergence characteristics, recovery time
and incidence of airway complications were all of inter-
est to be observed.
Methods
The study was approved by the Hospital Ethics Committee
of the Second Affiliated Hospital and Yuying Children's
Hospital of WenZhou Medical University. After a written
informed consent was obtained from the parents, a total of
75 children, aged 3–7 years old, American Society of Anes-
thesiologists (ASA) physical status I or II, scheduled to
undergo an adenotonsillectomy during the period of May
2016 to July 2016, were enrolled in this observational study
(trial registry identifier, ChiCTR-IOR-16008423). Patients
with suspected difficult airway, current upper respiratory
infections, asthma, mental diseases, or other congenital and
neurological diseases were excluded from the study.
All patients were required to follow the ASA fasting
guideline [9]. In the morning on the day of surgery, an
intravenous (IV) line was placed in the ward, and
patients were sent to a pre-anesthesia holding room
approximately 20 min before surgery in the presence of
one parent. Prior to any pre-medication, noninvasive
blood pressure, ECG, oxygen saturation (SPO2) and
heart rate were measured as baseline and then, were re-
corded continuously. Subjects were randomly allocated
to one of three groups (Group D1, Group D2 and Group
D0, n = 25 per group) by a computer-generated table of
random numbers. Prior to anesthesia induction, patients
in Group D1 and Group D2 received IV infusion of dex-
medetomidine (4 μg/mL normal saline) at 1 μg/kg and
2 μg/kg over 10 min respectively. Patients in Group D0
received saline infusion over 10 min.
Upon the completion of premed infusion, the patients
were transferred to the operating room. The monitoring
of vital signs were initiated and then, continued after.
Anesthesia was induced with sevoflurane (8%) in oxygen
at 5 L/min. When the pupils were deemed to be small
and central, the trachea intubation was performed with-
out muscle relaxants. Respiratory rate, tidal volume,
end-tidal carbon dioxide partial pressure (ETCO2), and
minimum alveolar concentration (MAC) of sevoflurane
were monitored. Patients who received rocuronium
(0.6 mg/kg) for failed intubation during the first 30 s at-
tempt, or who were persistently coughing after tracheal
intubation were excluded from the study. Prior to the
surgical incision, fentanyl (0.5 μg/kg), ondansetron
hydrochloride (0.1 mg/kg) and dexamethasone (0.2 mg/
kg) were administrated to all children, and 0.2% ropiva-
caine (0.25 mg/kg) with 1:200 000 epinephrine was
injected locally to the tonsil bed to provide additional
postoperative analgesia when surgery was finished. An
adequate depth of anesthesia was maintained with sevo-
flurane, and the patients were allowed breathing spon-
taneously throughout. Before the end of surgery,
sevoflurane were set to 1.5, 1.0 and 0.8 MAC in groups
D0, D1 and D2, respectively, and were maintained at the
same level for at least 10 min to achieve equilibration
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between the alveolar and brain. The concentration of
sevoflurane for group D0 was chosen based on the
precious study in which sevoflurane at 1.5 MAC may
provide a satisfactory deep extubation condition in chil-
dren [10]. The concentrations of sevoflurane for group
D1 and group D2 were determined based on the study
which was conducted in children, 1.0 μg/kg dexmedeto-
midine followed by a continuous infusion of 0.5 μg/kg/h
reduced ED50TI (50% excellent tracheal intubation
conditions) of sevoflurane by 33%, and 2.0 μg/kg dexme-
detomidine followed by a continuous infusion of
1.0 μg/kg/h reduced ED50TI of sevoflurane by 60%
[6], and based on the results of our pilot study.
Adequate spontaneous respiration was defined as a
normal ETCO2 waveform and an ETCO2 concentration
less than 6.0 kPa [11]. The ventilation was assisted
manually when ETCO2 concentration was over 7.2 kPa.
After surgery, patient was positioned on his or her
lateral side, the oropharynx was gently suctioned, and
the tracheal tube cuff was deflated. Once a stable spon-
taneous respiratory pattern was confirmed by ETCO2
monitoring, the endotracheal tube was removed gently
and quickly. Sevoflurane was discontinued and oxygen
(8 L/min) was administered via a facemask immediately
after extubation. An oral airway was placed only if the
patient had signs of obstructed airway. In addition, pro-
pofol 2 mg/kg and continuous positive airway pressure
(CPAP) would be used if patients developed breath hold-
ing or laryngospasm. Smooth tracheal extubation was
defined as no gross purposeful muscular movement,
such as coughing, breath holding or laryngospasm
within 1 min immediately after tracheal tube removal
[12]. Quality of extubation was assessed by using a 5
point rating scale [13] (Extubation Quality Score): 1 = no
coughing; 2 = minimal coughing (1 or 2 times); 3 =mod-
erate coughing (3 or 4 times); 4 = severe coughing (5–10
times) and straining; and 5 = poor extubation, very un-
comfortable (laryngospasm and coughing > 10 times). A
research observer who was blinded to the groups and
the drugs which the patient received was assigned to
evaluate the quality of extubation and the respiratory
complications (breathe holding, laryngospasm, broncho-
spasm and hypoxemia) and comply the data. Respiratory
and hemodynamic profiles were continuously monitored
throughout the procedure and until 5 min after extuba-
tion. Anesthesia time (time from sevoflurane induction
to sevoflurane discontinuation) and surgery time were
registered. The requirement of oral airway and airway
support were both noted.
Patients were transferred to the post-anesthesia care
unit (PACU) positioning on their lateral side when a pa-
tent airway and adequate spontaneous ventilation were
assured after extubation. The adequacy of the airway
was assessed by the criteria of SpO2 > 97% with 100%
oxygen, clear breath sounds and normal chest wall
movement. The pediatric anesthesia emergence delirium
scale (PAED) was used to diagnose the emergence agita-
tion (EA) in the PACU [14]. EA was defined to a total
score > 10. AS a rescue analgesic, fentanyl (0.5 μg/kg)
was administrated to the children who had EA. Patients
were discharged from the PACU when they had an
Aldrete score of 9–10, present of being calm, no pain
and nausea [15]. PAED score and the incidence of emer-
gence agitation, postoperative vomiting, any respiratory
complications and the fentainyl administration were
recorded. The recovery time (from extubation to spon-
taneous eye opening) and the actual time to discharge
from PACU were both noted.
Fan reported that the incidence of smooth extubation
was 88% in adult patients receiving 1.0 MAC sevoflurane
combined with dexmedetomidine 0.7 μg/kg [12]. A
power analysis performed before the initiation of our
study suggested that a sample size of 24 patients for
each group should be adequate to detect a 70% smooth
extubation at the 0.05 level with a power of 0.8.
The results were expressed in terms of [mean ± stand-
ard deviation (SD), n (%)] unless otherwise noted. Para-
metric data among groups were analyzed using One-way
analysis of variance and Mann–Whitney rank-sum test,
depending on the distribution of the data. Nominal
data were analyzed using either χ2 or Fisher’s exact
tests. P < 0.05 was considered statistically significant.
Results
A total of 75 eligible children were grouped into this study
(see Fig. 1, CONSORT flow diagram). There were no
dropouts or protocol violations and complete datasets
were available for all children. The demographic data (age,
sex and weight), the durations of surgery and anesthesia
were similar in three groups, as presented (see Table 1).
All tracheal tubes in the three groups were removed
successfully during deep anesthesia. Only two patients
developed minimal cough in group D0 and none in
Group D1 and Group D2. After extubation, nine patients
in Group D0, three in Group D1, and two in Group D2
required an oral airway. The frequency of oral airway in-
sertion in groups D1 and D2 were significantly lower
than that in Group D0, P < 0.05. No breath holding,
laryngospasm, bronchospasm and hypoxemia were
observed during extubation and after the extubation in
any of the groups. No re-intubation was required, as
shown (see Table 2). The hemodynamics profiles and re-
spiratory pattern were stable during tracheal extubation
in all groups. There were no significant differences in
respiratory rate, tidal volume, ETCO2, MAP, heart rate
and SPO2 before anesthesia induction, just before
extubation, during extubation, and at 1 and 5 min after
extubation among three groups.
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In the PACU, 11 patents in Group D0 exhibited ED
and were treated with fentanyl. No patient in Group
D1 and Group D2 had EA and required fentanyl ad-
ministration. The percentages of patients with ED and
the requirements of fentanyl in groups D1 and D2 and
were both significantly lower than those in Group D0.
The recovery time in Groups D2 and D0 were longer
than that in group D1. Furthermore, the recovery time
in Group D2 was also longer than that in group D0.
The times of PACU discharge were comparable in
Group D0 and Group D2, both longer than that in
Group D1, as shown (see Table 3). No respiratory com-
plications and the incidence of vomiting were observed
in PACU.
Fig. 1 CONSORT flow diagram
Table 1 Demographics and clinical characteristics
Variable Group D0 Group D1 Group D2
(n = 25) (n = 25) (n = 25)
Age (y) 5.3 ± 1.2 4.7 ± 1.0 4.9 ± 1.2
Sex (male/female) 14/11 10/15 13/12
Weight (kg) 19.8 ± 2.9 18.6 ± 2.8 19.4 ± 4.2
Anesthesia duration (min) 27.0 ± 4.2 27.0 ± 3.7 28.0 ± 2.7
Duration of surgery (min) 18.1 ± 3.5 18.8 ± 3.1 18.0 ± 2.9
Data are expressed as mean ± standard deviation (SD) (One-way ANOVA test)
or number of patients (Chi Square test)
Group D0 saline group, Group D1 dexmedetomidine group (1 μg · kg
−1), Group
D2 dexmedetomidine group (2 μg · kg
−1)
Table 2 Extubation characteristics, use of oral airway
Study group Group D0 Group D1 Group D2
(n = 25) (n = 25) (n = 25)
Smooth extubation 25(100.0) 25(100.0) 25(100.0)
Extubation Quality Score
no coughing 23(92.0) 25(100.0) 25(100.0)
minimal coughing 2(8.0) 0 0
moderate coughing 0 0 0
severe coughing 0 0 0
poor extubation 0 0 0
Use of oral airway 9(36.0) 3(12.0)* 2(8.0)*
Data are expressed as number of patients (%) (Chi-Square test)
Group D0 saline group, Group D1 dexmedetomidine group (1 μg · kg
−1), Group
D2 dexmedetomidine group (2 μg · kg
−1)
*P < 0.05 vs. Group D0
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Discussion
Our study results showed that a single intravenous injec-
tion of dexmedetomidine (1 μg/kg or 2 μg/kg) as pre-
medication allowed safe and smooth tracheal extubation
in children who were undergoing tonsillectomy and
anesthetized with low concentrations of sevoflurane, and
it also effectively prevented emergence agitation from
anesthesia. And dexmedetomidine at 1 μg/kg in combin-
ation with sevoflurane 1.0 MAC did not delay discharge
time from anesthesia.
Airway surgery in children, particularly tonsillectomy
posts a higher airway complications perioperatively
which frequently occurs following tracheal extubation
[16]. There has been ongoing debate regarding the tra-
cheal extubation strategies. Awake extubation technique
may increase the risk of complications, such as tonsillar
hemorrhage, over deep extubation, but, several other
studies did not find any differences of the perioperative re-
spiratory complications between two approaches [17, 18].
However, patients who experience the deep extubation
will have increased overall comfort as opposed to strenu-
ous coughing and gagging over the tube, less risk of
hemodynamic swings, less concern of tonsil bleeding and
less cough after extubation [17]. In addition, deep extuba-
tion could improve recovery, and prevent wound
dehiscence and bronchial spasm [10]. While an extremely
unpleasant experience of awake extubation may increase
the incidence of postoperative emergence agitation [19],
which has untoward impact on children in their early
recovery [20].
Dexmedetomidine is a selective α2-adrenoceptor agon-
ist. Intravenous dexmedetomidine completely blocked
histamine-induced bronchoconstriction in dogs [21].
Dexmedetomidine might benefical to decrease airway
reacitivity. Fan et al. found that, after intravenous injec-
tion of dexmedetomidine at 0.7 μg/kg 10 min before the
end of surgery, adjunctive sevoflurane could ensure deep
extubation without complications during spontaneous
breathing in adults [11]. Some clinicians have used dex-
medetomidine in combination with propofol to achieve
the adequate anesthesia plane for deep extubation in
children after airway reconstruction [22]. The purpose of
our study was to find out whether dexmedetomidine in
combination with low sevoflurane was able to facilitate
deep extubation in children undergoing tonsillectomy.
For inhalation anesthesia, a certain concentration of
inhaled anesthetic agent is required to meet the criteria
of deep extubation. Studies have shown that in the
absence of analgesic drugs, sevoflurane at 1.5 MAC may
provide a satisfactory deep extubation condition in chil-
dren [10]. The dose of sevoflurane required could be
significantly lowered if dexmedetomidine was given as a
pre-medication [3, 4]. He et al. found that a single injec-
tion of dexmedetomidine at 1 μg/kg before anesthesia
induction, then followed by continuous infusion of dex-
medetomidine at 0.5 μg/kg/h could reduce ED50TI of
sevoflurane by 33%, and a single injection of dexmedeto-
midine at 2 μg/kg before anesthesia induction followed
by continuous infusion of dexmedetomidine at 1 μg/kg/h
reduced ED50TI of sevoflurane by 66%, showing that
dexmedetomidine played a role in a dose-dependent
manner [6]. The distribution half-life of dexmedetomi-
dine was 3.2-5.5 min, and the elimination half-life of
dexmedetomidine is 2 h in children. Evidence showed
that dexmedetomidine at 0.4 μg/kg before anesthesia in-
duction could assist a minor ophthalmological clinic sur-
gery [3]. An uncomplicated tonsillectomy is a common
short-time surgery in children and may be completed
within 30 min. In this study, intravenous saline, dexme-
detomidine 1 μg/kg and dexmedetomidine 2 μg/kg were
given prior to anesthesia induction in group D0, D1 and
D2 respectively. A smooth extubation was observed in
all of the three groups even a lower sevoflurane was used
in group D1 (MAC 1.0) and group D2 (MAC 0.8) com-
pared to the sevoflurane-only D0 group (MAC 1.5).
Moderate to severe cough was not observed, too. Our
results indicated that Dexmedetomidine can facilitate
deep extubation process with less inhaled agent required.
Emergence agitation after general anesthesia with
sevoflurane is another major concern in children under-
going ENT surgery, and the causes are multi-factor di-
rected. Among those, a brief exposure of sevoflurane
anesthesia is one of the major contributors. The inci-
dence of emergence agitation is high (up to 80%) de-
pending on the definitions and methods of evaluation
[23, 24]. Deep extubation technique has been conducted
by some investigators, aiming to reduce emergence agi-
tation after sevoflurane anesthesia. However, the results
from a few other studies showed that the incidence of
emergence agitation in deep extubation was similar to
that after awake extubation [19]. It has been known that
preoperative anxiety was closely related to the increased
incidence of postoperative emergence agitation [25].
Theoretically, anti-anxiety pre-medication would help to
Table 3 Recovery variables in the post-anesthesia care unit
Study group Group D0 Group D1 Group D2
(n = 25) (n = 25) 0−(n = 25)
Emergence agitation (cases) 6(24) 0* 0*
Requirements of fentanyl (μg) 4.5 ± 0.9 0* 0*
Time from extubation to
spontaneous eye opening (min)
23.6 ± 5.0# 19.8 ± 4.3 27.5 ± 5.0*#
Time to discharge from PACU (min) 33.7 ± 7.4# 25.5 ± 5.0 32.8 ± 4.9#
Data are expressed as mean ± standard deviation (SD) (One-way ANOVA test)
or number of patients (%) (Chi Square test)
Group D0 saline group, Group D1 dexmedetomidine group (1 μg · kg
−1), Group
D2 dexmedetomidine group (2 μg · kg
−1)
*P < 0.05 vs. Group D0,
#P < 0.05 vs. Group D1
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reduce the incidence of post-operative agitation and de-
lirium. DEX is widely used in children as pre-medication
to alleviate preoperative anxiety and nervousness, to
optimize anesthesia induction by sevoflurane, and to im-
prove postoperative recovery after anesthesia. Yao et al.
[4] confirmed that intranasal dexmedetomidine at 2 μg/
kg relieved the preoperative anxiety and decreased post-
operative agitation. Bhadla et al. reported that a bolus in-
jection of dexmedetomidine at 0.4 μg/kg before surgery
could significantly lower the incidence of emergence agi-
tation after ophthalmological minor clinic surgery [3].
Our results showed that patients pre-medicated with a
single intravenous dexmedetomidine at 1 μg/kg in
Group D1 and dexmedetomidine at 2 μg/kg in Group D2
had significantly lower incidence of postoperative emer-
gence agitation compared to patients in group D0. Thus,
the data suggest that preoperative dexmedetomidine
administration do reduce postoperative emergence agita-
tion in a wide dosing range.
The sedation effect of dexmedetomidine was dose
dependent. The higher the dose of dexmedetomidine goes,
the better the sedation will be, but the concern is that a
high dose of dexmedetomidine may prolong the postoper-
ative recovery time. In addition, sevoflurane concentration
is also related to recovery time after anesthesia. In the
present study, the median recovery time was 23.6 min in
Group D0, which was comparable to the reported by Val-
ley et al. [10]. The time in Group D1 was 19.8 min, which
was a rapid awakening, whereas the time in Group D2 was
much longer (27.5 min) than in Group D0 and Group D1.
The difference might be due to the different concentra-
tions of sevoflurane and different doses of dexmedetomi-
dine pre-medication between the groups. The discharge
time in patients from Group D0, and D2 was comparable,
but much longer than in Group D1 patients. The pre-
sumptive explanation would be that patients in group D0
received additional fentanyl for treatment of emergence
agitation and patients in group D2 had higher dose of
dexmedetomidine (2 μg/kg).
The potential complications during deep extubation
include aspiration, airway obstruction, oxygen desatur-
ation, and airway spasm. In this study, the absence of
airway responsiveness and the continuation of regular
and spontaneous respiration after laryngopharyngeal
suction and the deflation of the endotracheal tube cuff
were used to determine whether patients were ready for
deep extubation. The recorded respiratory frequency,
tidal volume, and ETCO2 prior to extubation were com-
parable among groups, which was consistent with the
perception of dexmedetomidine having minimal effect
on respiration [26]. Dexmedetomidine has a very safe
therapeutic window with respect to respiratory depres-
sion, even if dexmedetomidine at a high dose [26]. How-
ever, 36% of children in Group D0 required an oral
airway after extubation, and this rate was significantly
higher than patients in groups D1 and D2, which may be
related to muscle relaxation induced by a high concen-
tration of sevoflurane [27].
Rapid bolus i.v. administration of dexmedetomidine has
possible hemodynamic side effect, it may alter the
hemodynamics, for example, by slowing heart rate and
modifying blood pressure, which are potential disadvan-
tages of dexmedetomidine. However, these adverse effects
can be minimized by slow IV infusion of dexmedetomidine
over 10 min. Our results showed that the hemodynamics
remained stable during extubation in the three groups.
One of the limitations for this study was that the plasma
concentration of dexmedetomidine was not monitored
during anesthesia. The correlation between the length and
depth of sedation and the hemodynamic changes of dex-
medetomidine in blood could not be analyzed.
Conclusions
In children undergoing tonsillectomy, single intravenous
dexmedetomidine pre-medication at 1 μg/kg or 2 μg/kg
could facilitate deep extubation in the presence of in-
haled low-concentration sevoflurane, which also reduces
the incidence of emergence agitation. Dexmedetomidine
at 1 μg/kg pre-medication did not prolong postoperative
recovery time.
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